Optimal management of a patient with recurrent nasopharyngeal carcinoma(90 visite) Perri F, Dell'Oca I, Muto P, Schiavone C, Aversa C, Fulciniti F, Solla R, Scarpati GD, Buonerba C, Di Lorenzo G, Caponigro F
World Journal Of Clinical Cases (ISSN: 2307-8960), 2014; 2(7): 297-300.
Tipo di articolo: Journal Article,
Impact factor: 0.895, Impact factor a 5 anni: 1.273
Url: Non disponibile.
Parole chiave: Cetuximab, Nasopharyngeal Carcinoma, Re-Irradiation, Surgery Of Metastases, Undifferentiated,
*** IBB - CNR *** Francesco Perri, Francesco Caponigro, Head and Neck Medical Oncology Unit, National Tumor Institute of Naples, 80131 Naples, Italy.
Nasopharyngeal carcinoma is rare in western countries, accounting for less than 1% of all malignancies. Despite prognosis is satisfactory for newly diagnosed, non-metastatic disease, management of recurrent disease is challenging, with a survival expectancy of approximately 6 mo with the use of chemotherapy as the sole salvage treatment. We report a case of recurrent nasopharyngeal carcinoma treated with a combination of chemotherapy, radiotherapy and surgery in the context of a multidisciplinary approach. A durable complete response was achieved.
10 Records (9 escludendo Abstract e Conferenze). Impact factor totale: 34.466 (33.831 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 34.682 (34.107 escludendo Abstract e Conferenze).